aDepartment of Ophthalmology, First Faculty of Medicine, Charles University in Prague
and General University Hospital in Prague and
bInstitute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine,
Charles University in Prague and General University Hospital in Prague, and
cFaculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech Republic
*Prof. Tomas Zima, MD, PhD, Institute of Clinical Biochemistry and Laboratory Diagnostics,
First Faculty of Medicine, Charles University in Prague, U. Nemocnice 2, CZ–128 08
Prague 2 (Czech Republic), Tel. +420 224 962 841, Fax +420 224 962 848, E-Mail zimatom@cesnet.cz
License:
Copyright: All rights reserved. No part of this publication may be translated into
other languages, reproduced or utilized in any form or by any means, electronic or
mechanical, including photocopying, recording, microcopying, or by any information
storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that
drug selection and dosage set forth in this text are in accord with current recommendations
and practice at the time of publication. However, in view of ongoing research, changes
in government regulations, and the constant flow of information relating to drug therapy
and drug reactions, the reader is urged to check the package insert for each drug
for any changes in indications and dosage and for added warnings and precautions.
This is particularly important when the recommended agent is a new and/or infrequently
employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely
those of the individual authors and contributors and not of the publishers and the
editor(s). The appearance of advertisements or/and product references in the publication
is not a warranty, endorsement, or approval of the products or services advertised
or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim
responsibility for any injury to persons or property resulting from any ideas, methods,
instructions or products referred to in the content or advertisements.